Perrigo (PRGO) Cash from Operations (2013 - 2026)
Perrigo's (PRGO) quarterly Cash from Operations came in at 113600000.0 in Q1 2026, down 76.12% year-on-year from 475792207.79 in Q1 2025, and down 164.77% on a QoQ basis from 175400000.0 in Q4 2025.
Perrigo (PRGO) Cash from Operations (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Cash from Operations data on file, last reported at 113600000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations fell 76.12% year-over-year to 113600000.0 in Q1 2026; TTM through Mar 2026 was 189400000.0, a 36.82% decrease from a year earlier, with the FY2025 full-year figure at 238500000.0, down 34.28% from the prior year.
- Cash from Operations for Q1 2026 stood at 113600000.0, down from 175400000.0 in the prior quarter.
- Over the last five years, Cash from Operations for PRGO reached as high as 312600000.0 in Q4 2024 and fell as low as 113600000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 70623529.41 across 5 years, with a median of 52900000.0 in 2023.
- Across the five-year window, Cash from Operations soared 39450.0% in 2022 and sank 4507.14% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 185900000.0 in 2022, then increased by 12.26% to 208700000.0 in 2023, then surged by 49.78% to 312600000.0 in 2024, then tumbled by 43.89% to 175400000.0 in 2025, then tumbled by 164.77% to 113600000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 113600000.0 in Q1 2026, 175400000.0 in Q4 2025, and 51700000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | -113.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -113.60 Mn |
| Mar 28, 2026 | -113.60 Mn |
| Dec 31, 2025 | 175.40 Mn |
| Dec 31, 2025 | 175.40 Mn |
| Sep 27, 2025 | 51.70 Mn |
| Sep 27, 2025 | 51.70 Mn |
| Jun 28, 2025 | 75.90 Mn |
| Jun 28, 2025 | 75.90 Mn |
| Mar 29, 2025 | -64.50 Mn |
| Mar 29, 2025 | -64.50 Mn |
| Dec 31, 2024 | 312.60 Mn |
| Dec 31, 2024 | 312.60 Mn |
| Sep 28, 2024 | 42.20 Mn |
| Sep 28, 2024 | 42.20 Mn |
| Jun 29, 2024 | 9.50 Mn |
| Jun 29, 2024 | 9.50 Mn |
| Mar 30, 2024 | -1.40 Mn |
| Mar 30, 2024 | -1.40 Mn |
| Dec 31, 2023 | 208.70 Mn |
| Dec 31, 2023 | 208.70 Mn |